Octagon Capital Advisors »

Corbus Pharmaceuticals Hldgs shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $16M 405k 39.24

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)
Alpine Immune Sciences (ALPN)
Dianthus Therapeutics (DNTH)
Verona Pharma Sponsored Ads (VRNA)
Dyne Therapeutics (DYN)
Arrivent Biopharma
Insmed Com Par $.01 (INSM)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Eyepoint Pharmaceuticals Com New (EYPT)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Bridgebio Pharma (BBIO)
Mind Medicine Mindmed Com New (MNMD)
IsoRay (CATX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Octagon Capital Advisors

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Point72 Asset Management
Ikarian Capital
Vanguard Group
Adage Capital Partners GP
Octagon Capital Advisors
Citadel Advisors
Henderson Group
Millennium Management
Assenagon Asset Management
BlackRock
T. Rowe Price Associates
Barclays
Morgan Stanley
Boothbay Fund Management

View all funds holding Corbus Pharmaceuticals Hldgs